Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
about
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-AnalysisPretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisSerum and urine biomarkers for human renal cell carcinomaComplex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein.Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinomaPretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.C-reactive protein as a prognostic factor for human osteosarcoma: a meta-analysis and literature review.Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma.The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma.Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinomaDiagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma.Neutrophil-lymphocyte ratio in small renal masses.Clinical and molecular prognostic and predictive biomarkers in clear cell renal cell cancer.The prognostic role of preoperative serum C-reactive protein in predicting the biochemical recurrence in patients treated with radical prostatectomy.Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis.Evaluation of ABO blood group as a prognostic marker in renal cell carcinoma (RCC).Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy
P2860
Q26751553-1C8CF8FA-392B-4548-98E3-C684A935737BQ26786160-3EAF6785-2A43-4491-83DA-580C048E69DAQ28084949-B1E19CD8-4F5E-4DB8-AC09-2DB853F49591Q33417707-35557D32-EB0B-4EC0-BE6E-456A224C0425Q34250582-E689DB25-B872-44D2-985F-9C8A90E2F363Q34354554-016BF413-ABB3-4BFE-A6E5-37492F70F59EQ35163616-A2BBCB03-06B0-4C8C-BBD0-55AF1ED19F1EQ36070506-B76D3FF4-DF4E-4F99-BC5F-56AE7FDED58EQ36784093-D765991E-61B0-4F8E-AA78-DF786BEFACB5Q37214300-EB189EAA-EBEF-4D77-8568-DF72875A6563Q37627345-2787ECC6-B8F5-421D-ADF3-A6F99955C254Q37679644-D6E0E0FC-EFAF-4854-BF38-5A125AB7A8B2Q38294622-B8A9B239-5A9A-45A1-97DC-49B08750CC06Q40062405-18B810D0-521D-49C1-9CB0-F90A95966142Q40968421-FE4F2C41-FA63-4FBE-B821-72DA59B5B080Q41624982-FCFB7C3C-3400-4CAB-B822-C892B407ECC6Q42365361-5A45F564-DD7A-4F37-B3B0-61BCA5247604Q45084644-33A489DB-7A88-4C92-84AE-6E9620C204C6Q46282864-7C6507A2-1559-4192-8EAD-A850759C93ECQ47687399-DB10C834-09FA-46FD-8BA6-8998C1E2F6C1Q50050944-C50C5E21-E482-46FE-8AE4-A258B75E6A4CQ59101351-2486299F-8106-4B63-991D-2FCE69EF39DD
P2860
Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Validation of serum C-reactive ...... ed renal cell carcinoma (RCC).
@en
Validation of serum C-reactive protein
@nl
type
label
Validation of serum C-reactive ...... ed renal cell carcinoma (RCC).
@en
Validation of serum C-reactive protein
@nl
prefLabel
Validation of serum C-reactive ...... ed renal cell carcinoma (RCC).
@en
Validation of serum C-reactive protein
@nl
P2093
P2860
P356
P1433
P1476
Validation of serum C-reactive ...... ed renal cell carcinoma (RCC).
@en
P2093
Andrea Haitel
Christoph Seemann
Georg Schatzl
Matthias Waldert
Mesut Remzi
Michela de Martino
Peter Weibl
Tobias Klatte
P2860
P304
P356
10.1111/BJU.12067
P577
2013-03-15T00:00:00Z